VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $973,000 | +23.8% | 4,900 | -10.7% | 0.32% | +17.7% |
| Q4 2014 | $786,000 | -2.5% | 5,490 | -10.6% | 0.27% | -8.4% |
| Q3 2014 | $806,000 | -80.6% | 6,140 | -81.4% | 0.30% | -81.0% |
| Q2 2014 | $4,153,000 | -54.6% | 32,926 | -52.5% | 1.56% | -14.4% |
| Q1 2014 | $9,138,000 | +115.4% | 69,312 | +91.8% | 1.82% | +7.3% |
| Q4 2013 | $4,242,000 | +11.9% | 36,136 | -0.6% | 1.70% | +1.3% |
| Q3 2013 | $3,791,000 | -39.9% | 36,341 | -50.4% | 1.68% | +19.4% |
| Q2 2013 | $6,308,000 | – | 73,282 | – | 1.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |